107 related articles for article (PubMed ID: 1425831)
1. Tissue polypeptide antigen for monitoring of advanced bladder cancer after MVEC chemotherapy.
Schmidt A; Bub P; Rüther U; Eisenberger F
Eur Urol; 1992; 21 Suppl 1():10-2. PubMed ID: 1425831
[TBL] [Abstract][Full Text] [Related]
2. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
Rassweiler J; Rüther U; Bäuerle K; Bub P; Jipp P; Eisenberger F
Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
[TBL] [Abstract][Full Text] [Related]
3. [Neoadjuvant chemotherapy of locally advanced tumors of the bladder: preliminary experience].
Ruoppolo M; Bellorofonte C; Gritti A; Gozo M; Ferri PM; Tura M; Zaatar C; Tiraboschi B; Morosini D; Dell'Acqua S
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):243-8. PubMed ID: 2142808
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant chemotherapy with MVC (methotrexate, vinblastine, cisplatin)in the treatment of infiltrating transitional carcinoma of the bladder].
Campo B; Torelli T; Leidi GL; Corrada P; Bacchioni AM; Ordesi G; Zanitzer L
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):237-42. PubMed ID: 2142807
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of methotrexate, vinblastine, doxorubicin and cisplatin adjuvant chemotherapy following radical surgery for locally invasive urothelial cancers: long-term results].
Tachibana M; Miyakawa A; Nakashima J; Nakamura K; Deguchi N; Baba S; Murai M; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1995 May; 86(5):1016-21. PubMed ID: 7596077
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95).
Lehmann J; Retz M; Wiemers C; Beck J; Thüroff J; Weining C; Albers P; Frohneberg D; Becker T; Funke PJ; Walz P; Langbein S; Reiher F; Schiller M; Miller K; Roth S; Kälble T; Sternberg D; Wellek S; Stöckle M;
J Clin Oncol; 2005 Aug; 23(22):4963-74. PubMed ID: 15939920
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].
Bellmunt Molins J; Ribas A; Albanell J; Lorente Garín JA; de Torres Mateos JA; Morote Robles J; López Palacios MA; Banús Gassol JM; Casado Cobo S; Eres N; Solé Calvo LA
Arch Esp Urol; 1996 Jun; 49(5):465-72. PubMed ID: 8766083
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.
Lancet; 1999 Aug; 354(9178):533-40. PubMed ID: 10470696
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract.
van der Gaast A; Kirkels WJ; Blijenberg BG; Splinter TA
J Cancer Res Clin Oncol; 1992; 118(8):626-8. PubMed ID: 1517284
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
Tsavaris N; Kosmas C; Skopelitis H; Dimitrakopoulos A; Kopterides P; Bougas D; Stravodimos K; Mitropoulos D; Alamanis C; Giannopoulos A
J Chemother; 2005 Aug; 17(4):441-8. PubMed ID: 16167525
[TBL] [Abstract][Full Text] [Related]
11. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
[TBL] [Abstract][Full Text] [Related]
12. Phase I-II pilot study on the efficacy and tolerability of neoadjuvant chemotherapy (Rescue M-VEC) and preoperative radiation therapy for infiltrating bladder cancer: results of an 18-month follow-up.
Voce S; Montanari F; Arnone S; Dal Pozzo C; Suprani G; Cerullo G; Fornarola V
Arch Esp Urol; 1992 Jun; 45(5):491-8. PubMed ID: 1510485
[TBL] [Abstract][Full Text] [Related]
13. [Infiltrating tumors of the bladder. Local response to systemic platinum-based chemotherapy].
Boccon-Gibod L; Adjiman S; Beuzeboc P; Steg A
Ann Urol (Paris); 1989; 23(4):285-8. PubMed ID: 2686541
[TBL] [Abstract][Full Text] [Related]
14. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study.
de la Rosa F; Garcia-Carbonero R; Passas J; Rosino A; Lianes P; Paz-Ares L
J Urol; 2002 Jun; 167(6):2413-8. PubMed ID: 11992048
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant M-VEC in advanced urotheliomas of the bladder].
Cocimano V; Marino G; Brigato R; Pacilli N; Buffa G; Marten Perolino R
Minerva Urol Nefrol; 1989; 41(3):195-7. PubMed ID: 2617375
[TBL] [Abstract][Full Text] [Related]
16. A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer.
Cacciari N; Martoni A; Rossi AP; Turci P; Lelli G; Martinelli A; Maver P; Corrado F; Mannini D; Reggiani A; Concetti S; Martelli A; Melotti B; Cricca A; Zamagni C; Pannuti F
Tumori; 1996; 82(4):364-8. PubMed ID: 8890971
[TBL] [Abstract][Full Text] [Related]
17. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.
Matsui Y; Nishiyama H; Watanabe J; Teramukai S; Ono Y; Ohshima S; Fujimoto K; Hirao Y; Fukushima M; Ogawa O
Int J Clin Oncol; 2005 Apr; 10(2):133-8. PubMed ID: 15864700
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant chemotherapy in infiltrating bladder carcinoma. Long-term results].
Marino G; Cocimano V; Cevoli R; Marten Perolino R
Minerva Urol Nefrol; 1993 Sep; 45(3):113-5. PubMed ID: 8278877
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant systemic chemotherapy with VMC (vinblastine, methotrexate and cisplatin) in locally advanced carcinoma of the bladder].
Maffezzini M; Rigatti P
Arch Ital Urol Nefrol Androl; 1990 Jun; 62(2):219-21. PubMed ID: 2142804
[TBL] [Abstract][Full Text] [Related]
20. [Neoadjuvant and adjuvant chemotherapy of bladder cancer].
Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():362-9. PubMed ID: 7986116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]